Free GLP-1 medication exists — but with significant eligibility restrictions. Here's every legitimate pathway to free or near-free GLP-1 treatment in 2026, ranked by accessibility, plus the cheapest alternatives when you don't qualify.
Tier 1: Actually Free (With Insurance)
Manufacturer savings cards + commercial insurance
If your commercial insurance covers a GLP-1 medication, manufacturer savings cards can reduce your copay to $0-25/month. This is the cheapest legitimate pathway for anyone with employer-sponsored or individual commercial insurance.
| Savings Card | Medication | Copay With Card | Eligible | Not Eligible |
|---|---|---|---|---|
| Novo Nordisk Savings | Wegovy (inj + oral) | $0-25/mo | Commercial insurance | Medicare, Medicaid, gov't |
| Novo Nordisk Savings | Ozempic | $25/mo | Commercial insurance | Medicare, Medicaid, gov't |
| Foundayo Savings Card | Foundayo | $25/mo | Commercial insurance | Medicare, Medicaid, gov't |
| Zepbound Savings Card | Zepbound | $25/mo | Commercial insurance | Medicare, Medicaid, gov't |
Tier 2: Near-Free ($50/month)
Medicare GLP-1 Bridge (starting July 1, 2026)
Medicare Part D beneficiaries with BMI ≥35 (or ≥27 with comorbidities) can access Wegovy, Foundayo, and Zepbound KwikPen for a $50/month copay. This is the first time Medicare has ever covered weight-loss medications. See our full enrollment guide for preparation steps.
Tier 3: Patient Assistance Programs (Income-Based Free)
Novo Nordisk Patient Assistance Program (PAP)
Provides Wegovy and Ozempic at no cost to qualifying patients. Eligibility typically requires: US residence, no prescription drug insurance coverage for the requested medication, and household income at or below 400% of the Federal Poverty Level (approximately $60,000 for an individual, $124,800 for a family of 4 in 2026). Application requires prescriber involvement and takes 4-6 weeks to process.
Eli Lilly Lilly Cares Foundation
Provides Zepbound and Mounjaro at no cost to qualifying patients. Similar income requirements to Novo's PAP. As of May 2026, Foundayo is NOT yet included in Lilly Cares — this may change as the program expands.
Limitations of PAPs
Patient assistance programs are slow (4-6 week approval), require annual re-certification, and can be discontinued if your income changes. They're a genuine lifeline for low-income patients but aren't a practical solution for most working adults above the income threshold.
Tier 4: State and Community Programs
Some states cover GLP-1s through Medicaid for diabetes indications. Coverage for weight-loss-only indications is rare in Medicaid. Community health centers (FQHCs) may offer GLP-1 prescriptions with sliding-scale pricing. Check your state Medicaid formulary and local FQHC directory.
When Free Isn't Available: Cheapest Alternatives
If you don't qualify for savings cards (no insurance), PAPs (income too high), or Medicare (under 65, not disabled), your cheapest options are:
| Provider | Monthly Cost | What You Get | Best For |
|---|---|---|---|
| GobyMeds | $99/mo | Compounded sema, flat rate | Lowest possible cash cost |
| Oak Longevity | $130/mo | Compounded sema + coaching | Value + clinical support |
| GobyMeds tirz | $133/mo | Compounded tirzepatide | Max weight loss, budget |
| Wegovy oral (NovoCare) | $149/mo starter | FDA-approved brand-name pill | Brand-name + needle-free |
| Foundayo (LillyDirect) | $149/mo starter | FDA-approved brand-name pill | No food restrictions |
| BiltRx | See pricing | Compounded programs | Licensed pharmacy access |